Posted by Michael Wonder on 23 Jan 2024
TGA approves RSV vaccine for use through private prescription for Australians over 60
17 January 2024 - A vaccine for respiratory syncytial virus has been approved by the TGA and will be available through private prescriptions for those 60 and above "very soon".
Approved for use by the TGA on 8 January 8, Arexvy is a protein based vaccine for the prevention of lower respiratory tract disease caused by respiratory syncytial virus, which can be fatal.
